RECRUITINGOBSERVATIONAL
Sleep-disordered Breathing After Solid Organ Transplantation
About This Trial
Sleep-disordered breathing (SDB) describes a group of disorders in which partial or complete cessation of breathing occurs many times throughout the night, resulting in daytime sleepiness or fatigue that interferes with a person's ability to function and reduces quality of life. Transplantation has become an important treatment modality for end-stage organ failure. Transplant recipients are now living longer and, hence, develop chronic adverse medical conditions. Furthermore, transplantation is associated with weight gain. Despite the high prevalence of poor sleep and cardiovascular conditions among transplant patients, SDB is not well studied in these patients.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients 1 year after lung transplantation
Who Should NOT Join This Trial:
- Refusal of PSG
- Medical contra-indication to perform PSG
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients 1 year after lung transplantation
Exclusion Criteria:
* Refusal of PSG
* Medical contra-indication to perform PSG
Treatments Being Tested
OTHER
No intervention - Diagnostic polysomnography at 1 year after lung transplantation
Locations (1)
UZ Leuven
Leuven, Belgium